Adma Biologics Inc (ADMA)

Operating Cash Flow (Statement)

$29.54M

Quarterly · Period ending: · USD

ADMA logo

ADMA Operating Cash Flow (Statement)

Latest reported$29.54M
ADMA Quarterly Cash from Operations (-$4.72M → $29.54M)
High-resolution chart · PNG

ADMA operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Adma Biologics Inc Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
29,539,000
58,249,000
35,639,000
13,293,000
21,139,000
-19,675,000
50,216,000
25,028,000
45,646,000
-2,218,000
17,595,952
11,985,000
-6,058,756
-14,723,000
-7,379,315
-13,284,761
-12,830,768
-26,013,413
-33,465,232
-13,412,387
-32,262,237
-33,229,126
-32,219,436
-23,852,087
-21,284,475
-24,646,960
-19,652,036
-23,630,332
-18,623,952
-14,287,184
-18,793,124
-12,543,405
-14,908,039
-16,434,114
-13,358,629
-9,739,371
-8,775,348
-5,398,426
-3,613,678
-4,683,188
-4,804,177
-5,167,930
-4,078,209
-2,673,053
-4,446,367
-4,220,775
-2,902,433
-2,465,868
-4,296,279
-5,040,330
-2,959,763
-2,225,662
-2,626,958
-3,074,771
-1,807,050
-2,101,188
-996,858
-1,998,699
-12,830
-5,183
-7,680
-3,908
-9,019
-8,393
-1,922
-3,910
-8,426,000
-5,418,000
-4,420,000
-4,420,000
3,386,000
-3,922,000
-2,218,000
-6,018,000
-6,847,000
-2,011,000
-2,370,000
-4,720,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.